Papaya Leaf Juice for Dengue: Does It Raise Platelets? What Trials Found

As a pharmacist, the useful way to judge any remedy is to ask three questions. Does it change the measurement it claims to change? Does changing that measurement help the patient? And what does it cost in side effects or delay? Papaya leaf answers the first question weakly, the second not at all, and the third better than many remedies do.

Does papaya leaf juice increase platelets?

It may, modestly, but the evidence is weak. Small trials, mostly from India, Pakistan, Malaysia and Indonesia, report that patients given papaya leaf juice or extract had higher platelet counts after a few days than patients who were not. The best of these studies were open-label, meaning patients and doctors knew who received the remedy, and many compared groups that differed in other ways. Platelet counts in dengue also rise naturally once the critical phase passes, which makes a before-and-after story almost worthless. So the honest answer is a possible small effect on a laboratory number, not a proven treatment for dengue.

Where the papaya leaf belief came from

Papaya leaf has long been used in folk medicine across South and South-East Asia for fevers and malaria, and the dengue use spread widely in the 2000s. Laboratory and animal studies suggested that leaf compounds, including flavonoids and other plant chemicals, might protect platelet membranes or stimulate their production, though animal models are a long way from a person with dengue. Case reports then described dramatic recoveries after the juice, and they travelled fast on social media. A 2024 case report from Trinidad and Tobago described a 65-year-old woman whose platelets rose from 12.1 to 122.7 within two days of starting the extract. Single cases cannot separate the remedy from the recovery that was already coming.

What did the largest trial of papaya leaf juice find?

The most cited trial found faster platelet rises, but it was unblinded and short. Researchers at Malaysia's Institute for Medical Research randomised 228 patients with dengue fever and dengue haemorrhagic fever in a study published in 2013. About half received fresh papaya leaf juice for 3 consecutive days alongside standard care, and the rest received standard care alone. Mean platelet counts were significantly higher in the juice group at 40 and 48 hours, and two genes linked to platelet production were more active. The trial did not use a placebo, did not blind patients or staff, and did not report whether bleeding, leakage or shock became less common.

What do the meta-analyses conclude?

Both published meta-analyses found small benefits on weak evidence and called for better trials. In 2016, Indian researchers pooled four randomised trials with 439 patients and found platelet counts modestly higher with papaya leaf extract, but with no significant difference at 48 hours, and hospital stays about 1.90 days shorter; mortality and adverse events could not be pooled because the trials did not report them properly. A 2019 Sri Lankan review of nine studies, six of them from India, found seven showing higher counts and a hospital stay 1.98 days shorter. Its authors rated the evidence low quality and said it was insufficient to judge the extract's role in dengue.

Why a rising platelet count can mislead

In dengue, the platelet count usually falls through the febrile and critical phases, reaches its lowest point around the time the fever settles, and then climbs by itself over the next few days. Any remedy given at the bottom of that curve will appear to work. This is why controlled trials matter, and why an open-label trial, where doctors decide on discharge knowing who took the juice, can overstate benefit. Shorter hospital stays sound meaningful, yet discharge decisions in these studies were often tied to the platelet count itself. If the remedy nudges the number, the patient goes home sooner, even if nothing else about the illness has changed.

Does a higher platelet count mean a safer patient?

Not necessarily, and this is the gap in the papaya evidence. The most serious dangers in dengue come from plasma leakage, which can lead to shock, and from bleeding, and neither tracks the platelet count neatly. A Lancet trial in Singapore and Malaysia tested the most direct way to raise platelets, preventive platelet transfusion, in adults with counts of 20,000 or below. Bleeding occurred in 21 per cent of transfused patients and 26 per cent of controls, a difference that was not significant, and transfusion caused more adverse events. If giving platelets directly did not prevent bleeding, a modest rise from leaf juice cannot be assumed to.

Can papaya leaf juice cause side effects?

Yes, and in dengue the commonest one matters. The juice is intensely bitter, and nausea and vomiting are frequently reported; persistent vomiting is itself a dengue warning sign and worsens dehydration, so a remedy that makes a patient sick does harm. Trials rarely reported serious adverse events, but they also reported safety poorly, which is not the same as proving safety. Raw leaves washed badly can carry contamination. Some laboratory and animal studies suggest papaya extracts may affect blood sugar and clotting, so people on diabetes medicines or blood thinners such as warfarin should not take it without their doctor's agreement. Allergy to papaya or latex is another reason to avoid it.

How much papaya leaf juice should you drink?

There is no proven dose, and nobody should set one for a dengue patient except the treating doctor. The trials used different preparations: fresh juice from pounded leaves in some, and standardised capsules, tablets or syrups in others, given for varying numbers of days. The strength of fresh juice depends on the leaves, how much water is added and how it is strained, so a kitchen glass cannot be matched to any trial. Forcing extra glasses on a nauseous patient replaces fluids that would actually help. If a family wants to use it, the right step is to ask the doctor managing the case, not a forwarded message.

Are papaya leaf tablets and syrups better than fresh juice?

They are more consistent, but not better proven. Several Indian studies used standardised extract tablets or capsules, which give a known amount of extract and avoid the bitterness and hygiene problems of home juice. These products are generally sold under Ayurvedic drug licences, and a licence to sell is not the same as evidence that a product changes outcomes. Some combine papaya leaf with giloy or other herbs, which adds ingredients the trials did not test, and Indian liver specialists have reported injury linked to giloy products. A standard preparation makes a future high-quality trial possible; it does not substitute for one.

Is papaya leaf safe in pregnancy?

Avoid it. No trial has tested papaya leaf extract in pregnant women, and unripe papaya contains latex and the enzyme papain, which have raised concern about uterine contractions in animal studies. Leaf preparations are not the same as ripe fruit, but there is no safety data to lean on, and dengue in pregnancy already needs close hospital supervision because leakage and bleeding are harder to manage. Pregnant women with dengue should be under an obstetrician and physician together, and any remedy should be cleared with them first. Whether ripe papaya fruit is fine in pregnancy is covered in papaya or pineapple in pregnancy.

Is ripe papaya fruit good in dengue?

Yes, ripe papaya fruit is a sensible food during dengue, though it does not raise platelets. It is soft, easy to eat when appetite is poor, and gives vitamin C, folate, potassium, carotenoids and some fibre and fluid. A small bowl of ripe papaya between meals fits well with the soft, fluid-rich diet dengue calls for. The fruit and the leaf are different materials with different chemistry, and the platelet trials all used leaves. The full food and fluid plan, including foods to avoid and when to go to hospital, is set out in the dengue diet chart.

What actually helps a dengue patient recover?

Rest, steady fluids, fever control with the medicine the doctor recommends, and close watching for warning signs are what help. There is still no antiviral for dengue, and a 2019 Lancet review describes management as careful observation with prompt, judicious intravenous fluids for patients who develop significant leakage. At home that means ORS, coconut water, dal water, soups and soft food little and often. It means avoiding aspirin, ibuprofen and similar painkillers unless a doctor has approved them. And it means going to hospital immediately for abdominal pain, repeated vomiting, bleeding, drowsiness, cold hands and feet, or no urine for several hours.

When is it reasonable to try papaya leaf?

Only as an add-on that the treating doctor has agreed to, in a patient who can keep fluids down, and never in place of monitoring or admission. Some Indian physicians do allow standardised extract tablets alongside supportive care, reasoning that the risk looks low and a shorter stay has value. That is a defensible clinical choice. Where it goes wrong is when a family watches the platelet report and the juice glass, feels reassured by a rising number, and misses the abdominal pain or the drowsy child that signalled leakage. The remedy is not the danger in those cases; the false reassurance is.

Judging a remedy the way a pharmacist does

People ask nutritionists about papaya leaf, giloy, kiwi and a dozen supplements every dengue season. Answering responsibly takes the ability to read a trial, spot an unblinded design, separate a surrogate number from a real outcome, and flag interactions with medicines. That evaluation is the backbone of NNWA's Dietary Supplements and Nutraceuticals course, taught with faculty such as Sandeep Ojha, a registered pharmacist with an M.Pharm in pharmacology, listed on the NNWA team page. The course covers herbal products, labels, safety and evidence against hype, with lifetime access to class recordings and a certificate anyone can verify.

The short version

Papaya leaf juice or extract may raise platelet counts a little faster in dengue, and pooled studies suggest hospital stays about two days shorter. The trials were small, mostly unblinded and poorly reported on safety, and none showed fewer cases of bleeding, shock or death. Raising platelets does not by itself make a patient safer. There is no proven dose, the bitterness can cause vomiting, and it should be avoided in pregnancy and cleared with a doctor by anyone on diabetes medicines or blood thinners. Ripe papaya fruit is a good food. Fluids, monitoring and prompt hospital care are the treatment.

Research this article draws on

Rajapakse et al. (2019). Carica papaya extract in dengue: a systematic review and meta-analysis. BMC Complementary and Alternative Medicine. Nine studies, six from India, mostly showed higher platelet counts and a hospital stay 1.98 days shorter, but the evidence was low quality and insufficient to judge any effect on leakage or death.

Charan et al. (2016). Efficacy and safety of Carica papaya leaf extract in the dengue: A systematic review and meta-analysis. International Journal of Applied and Basic Medical Research. Four trials with 439 patients showed modestly higher platelets overall, no difference at 48 hours and shorter hospital stays; mortality and adverse events could not be pooled, so larger trials are needed.

Subenthiran et al. (2013). Carica papayaLeaves Juice Significantly Accelerates the Rate of Increase in Platelet Count among Patients with Dengue Fever and Dengue Haemorrhagic Fever. Evidence-Based Complementary and Alternative Medicine. In an open-label randomised trial of 228 Malaysian patients, three days of leaf juice gave higher platelet counts at 40 and 48 hours; bleeding and shock outcomes were not reported.

Jaggernauth et al. (2024). Is Papaya Leaf Extract the Sweet Remedy for Dengue-Induced Thrombocytopenia?. Cureus. A single case report describing a sharp platelet rise after papaya leaf extract; as one patient in natural recovery, it cannot show that the extract caused the change.

Lye et al. (2017). Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial30269-6). The Lancet. Raising platelets directly by transfusion did not significantly reduce bleeding in adults with dengue and increased adverse events, which questions platelet count as a target in itself.

Wilder-Smith et al. (2019). Dengue32560-1). The Lancet. With no effective antiviral available, this review describes dengue care as careful observation plus prompt, judicious intravenous fluids for patients with substantial vascular leakage.